CA3017836A1 - Novel alpha-1-microglobulin derived proteins and their use - Google Patents
Novel alpha-1-microglobulin derived proteins and their use Download PDFInfo
- Publication number
- CA3017836A1 CA3017836A1 CA3017836A CA3017836A CA3017836A1 CA 3017836 A1 CA3017836 A1 CA 3017836A1 CA 3017836 A CA3017836 A CA 3017836A CA 3017836 A CA3017836 A CA 3017836A CA 3017836 A1 CA3017836 A1 CA 3017836A1
- Authority
- CA
- Canada
- Prior art keywords
- absent
- asp
- seq
- human
- met
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4717—Plasma globulins, lactoglobulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA201670158 | 2016-03-18 | ||
| DKPA201670158 | 2016-03-18 | ||
| PCT/EP2017/056436 WO2017158181A1 (en) | 2016-03-18 | 2017-03-17 | Novel alpha-1-microglobulin derived proteins and their use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3017836A1 true CA3017836A1 (en) | 2017-09-21 |
Family
ID=56080208
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3017836A Pending CA3017836A1 (en) | 2016-03-18 | 2017-03-17 | Novel alpha-1-microglobulin derived proteins and their use |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US10981963B2 (enExample) |
| EP (1) | EP3430032B1 (enExample) |
| JP (1) | JP6976579B2 (enExample) |
| KR (1) | KR102437662B1 (enExample) |
| CN (1) | CN108779157B (enExample) |
| AU (1) | AU2017235608B2 (enExample) |
| CA (1) | CA3017836A1 (enExample) |
| EA (1) | EA039776B1 (enExample) |
| ES (1) | ES2896734T3 (enExample) |
| MX (1) | MX2018011193A (enExample) |
| NZ (1) | NZ746677A (enExample) |
| SG (1) | SG11201807352XA (enExample) |
| WO (1) | WO2017158181A1 (enExample) |
| ZA (1) | ZA201805797B (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3703729A1 (en) * | 2017-11-03 | 2020-09-09 | Guard Therapeutics International AB | Use of alpha-1-microglobulin for protection of bone marrow cells |
| AU2024219294A1 (en) | 2023-02-08 | 2025-07-10 | Guard Therapeutics International AB | Alpha-1-microglobulin derived peptide fragments and uses thereof |
| US12227343B2 (en) * | 2023-03-17 | 2025-02-18 | Blue Buffalo Enterpises, Inc. | Retail ready opening feature for e-commerce carton |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2313106T3 (en) * | 2008-07-18 | 2016-07-25 | A1M Pharma Ab | MEDICAL USE OF RADICAL binder and the antioxidant is alpha-1-microglobulin |
| US9758554B2 (en) * | 2012-01-31 | 2017-09-12 | Technische Universitaet Muenchen | Muteins of α1m lipocalin and method of production therefor |
| PL2900254T3 (pl) * | 2012-09-05 | 2017-02-28 | A1M Pharma Ab | Alfa-1 mikroglobulina do użycia w leczeniu chorób związanych z mitochondriami |
| WO2014047490A1 (en) * | 2012-09-21 | 2014-03-27 | Beintoo, S.P.A. | Interactive experience fully contained within an expandalble embedded unit |
| US10226570B2 (en) * | 2017-03-10 | 2019-03-12 | Seton Healthcare Family | Apparatus and method for temporarily securing a movable accessory device relative to a movable patient |
-
2017
- 2017-03-17 SG SG11201807352XA patent/SG11201807352XA/en unknown
- 2017-03-17 AU AU2017235608A patent/AU2017235608B2/en active Active
- 2017-03-17 WO PCT/EP2017/056436 patent/WO2017158181A1/en not_active Ceased
- 2017-03-17 US US16/085,500 patent/US10981963B2/en active Active
- 2017-03-17 NZ NZ746677A patent/NZ746677A/en unknown
- 2017-03-17 MX MX2018011193A patent/MX2018011193A/es unknown
- 2017-03-17 EA EA201892085A patent/EA039776B1/ru unknown
- 2017-03-17 EP EP17711205.9A patent/EP3430032B1/en active Active
- 2017-03-17 CN CN201780018244.4A patent/CN108779157B/zh active Active
- 2017-03-17 KR KR1020187029939A patent/KR102437662B1/ko active Active
- 2017-03-17 ES ES17711205T patent/ES2896734T3/es active Active
- 2017-03-17 CA CA3017836A patent/CA3017836A1/en active Pending
- 2017-03-17 JP JP2018548761A patent/JP6976579B2/ja active Active
-
2018
- 2018-08-29 ZA ZA2018/05797A patent/ZA201805797B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR112018068522A2 (pt) | 2019-01-22 |
| US10981963B2 (en) | 2021-04-20 |
| WO2017158181A1 (en) | 2017-09-21 |
| EA039776B1 (ru) | 2022-03-11 |
| EA201892085A1 (ru) | 2019-02-28 |
| MX2018011193A (es) | 2019-03-28 |
| CN108779157A (zh) | 2018-11-09 |
| ZA201805797B (en) | 2022-03-30 |
| ES2896734T3 (es) | 2022-02-25 |
| KR102437662B1 (ko) | 2022-08-29 |
| KR20180127411A (ko) | 2018-11-28 |
| NZ746677A (en) | 2023-02-24 |
| US20190161524A1 (en) | 2019-05-30 |
| CN108779157B (zh) | 2022-12-30 |
| SG11201807352XA (en) | 2018-09-27 |
| EP3430032A1 (en) | 2019-01-23 |
| EP3430032B1 (en) | 2021-09-01 |
| AU2017235608B2 (en) | 2020-10-22 |
| JP2019519466A (ja) | 2019-07-11 |
| JP6976579B2 (ja) | 2021-12-08 |
| AU2017235608A1 (en) | 2018-10-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU784845B2 (en) | Cell-permeable peptide inhibitors of the JNK signal transduction pathway | |
| US20120282285A1 (en) | Masp isoforms as inhibitors of complement activation | |
| US10981963B2 (en) | Alpha-1-microglobulin derived proteins and their use | |
| US10456448B2 (en) | PTD-SMAD7 therapeutics | |
| CN107412729A (zh) | 用于治疗肾病综合征和有关病症的方法 | |
| KR20080106450A (ko) | 단백질, 핵산 및 약제 | |
| KR102221041B1 (ko) | 신증후군 및 관련 병태의 치료 방법 | |
| AU2003234066B2 (en) | Muteins of placental growth factor type 1, preparation method and application thereof | |
| Tejada et al. | Cloning of an avian antithrombin: developmental and hormonal regulation of expression | |
| HK1114123A (en) | Cell-permeable peptide inhibitors of the jnk signal transduction pathway | |
| HK1111730A (en) | Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20220316 |
|
| D15 | Examination report completed |
Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT Effective date: 20240731 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - RESPONSE TO EXAMINER'S REQUISITION Effective date: 20241128 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20250203 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 8TH ANNIV.) - STANDARD Year of fee payment: 8 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250226 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT Effective date: 20250226 Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250226 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT Effective date: 20250529 |
|
| P13 | Application amended |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED Effective date: 20250529 |
|
| D15 | Examination report completed |
Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT Effective date: 20251029 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20260504 |